FDA WARNING_LETTER - KetoKerri LLC - August 09, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA issued a Warning Letter to Kerri Rivera regarding the sale of unapproved and misbranded products related to COVID-19. Between March 12 and August 9, 2020, the FDA reviewed Rivera's websites (www.kerririvera.com, www.ketokerri.com), Amazon storefront, and Facebook page. The review found products like "KK Black Seed Oil," "KK Breakthrough Vitamin D," "Stonebreaker," "KK EDTA," "Zeolite," "Ultra Liquid Zeolite," and "DR. FITT FIRE FIGHTERS" were offered for sale with claims to mitigate, prevent, treat, diagnose, or cure COVID-19.
These products were deemed unapproved new drugs under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of such products into interstate commerce violates sections 301(a) and (d) of the FD&C Act (21 U.S.C. § 331(a) and (d)). The letter notes that while some claims have been removed and the Facebook page is down, the violations are serious public health concerns.
Rivera is required to email COVID-19-Task-Force-CFSAN
ID · 942543f0-e88d-4d8f-93d5-36fb9b17f94e
Full citation text and observation details available on the Dashboard.